Patricia Rosas-Gomez
Unidad Del Seguro Social En Santa Fe, DIF 06720, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.
Journal: Cancers
Published: July 14, 2025
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 16, 2024
A Ten-Year Experience with the Diagnosis of Von Willebrand Disease in Mexico Based on a Cost-Effective Strategy.
Journal: Archives of medical research
Published: April 17, 2024
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.
Journal: Frontiers in cardiovascular medicine
Published: March 15, 2022
Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: January 07, 2021
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: September 23, 2020
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study.
Journal: American journal of hematology
Published: January 17, 2020
von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: August 01, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026